Search Results

There are 7009 results for: content related to: HBeAg and hepatitis B virus DNA as outcome predictors during therapy with peginterferon alfa-2a for HBeAg-positive chronic hepatitis B

  1. You have free access to this content
    JSH Guidelines for the Management of Hepatitis B Virus Infection

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 1–58, Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology

    Version of Record online : 7 JAN 2014, DOI: 10.1111/hepr.12269

  2. You have free access to this content
    HBV Trials and Treatments

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 647A–705A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26856

  3. You have free access to this content
    Poster Session IV (Abstracts 1638 – 2112)

    Hepatology

    Volume 64, Issue S1, October 2016, Pages: 811–1050,

    Version of Record online : 1 OCT 2016, DOI: 10.1002/hep.28800

  4. You have free access to this content
    Poster Session 4: Hepatitis B Therapy

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 1088A–1128A,

    Version of Record online : 1 OCT 2014, DOI: 10.1002/hep.27532

  5. You have free access to this content
    Age-specific prognosis following spontaneous hepatitis B e antigen seroconversion in chronic hepatitis B

    Hepatology

    Volume 51, Issue 2, February 2010, Pages: 435–444, Yi-Cheng Chen, Chia-Ming Chu and Yun-Fan Liaw

    Version of Record online : 29 SEP 2009, DOI: 10.1002/hep.23348

  6. Long-term effect of maternal HBeAg on delayed HBeAg seroconversion in offspring with chronic hepatitis B infection

    Liver International

    Volume 31, Issue 9, October 2011, Pages: 1373–1380, Yu-Ru Tseng, Jia-Feng Wu, Yen-Hsuan Ni, Huey-Ling Chen, Chih-Cheng Chen, Wan-Hsin Wen, Hong-Yuan Hsu and Mei-Hwei Chang

    Version of Record online : 28 JUN 2011, DOI: 10.1111/j.1478-3231.2011.02574.x

  7. Quantitative serum HBsAg and HBeAg are strong predictors of sustained HBeAg seroconversion to pegylated interferon alfa-2b in HBeAg-positive patients

    Journal of Gastroenterology and Hepatology

    Volume 25, Issue 9, September 2010, Pages: 1498–1506, Hui Ma, Rui-feng Yang and Lai Wei

    Version of Record online : 3 FEB 2010, DOI: 10.1111/j.1440-1746.2010.06282.x

  8. You have free access to this content
    Chronic hepatitis B

    Hepatology

    Volume 45, Issue 2, February 2007, Pages: 507–539, Anna S. F. Lok and Brian J. McMahon

    Version of Record online : 26 JAN 2007, DOI: 10.1002/hep.21513

  9. You have free access to this content
    Current treatments for patients with HBeAg-positive chronic hepatitis B virus infection: a comparison focusing on HBeAg seroconversion

    Liver International

    Volume 30, Issue 4, April 2010, Pages: 512–520, George K. K. Lau

    Version of Record online : 19 JAN 2010, DOI: 10.1111/j.1478-3231.2009.02198.x

  10. You have free access to this content
    Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion

    Hepatology

    Volume 57, Issue 3, March 2013, Pages: 934–943, Hung-Chih Yang, Chi-Ling Chen, Yueh-Chi Shen, Cheng-Yuan Peng, Chun-Jen Liu, Tai-Chung Tseng, Tung-Hung Su, Wan-Long Chuang, Ming-Lung Yu, Chia-Yen Dai, Chen-Hua Liu, Pei-Jer Chen, Ding-Shinn Chen and Jia-Horng Kao

    Version of Record online : 7 FEB 2013, DOI: 10.1002/hep.26121

  11. You have free access to this content
    Predictors of hepatitis B e antigen-negative hepatitis in chronic hepatitis B virus-infected patients from childhood to adulthood

    Hepatology

    Volume 63, Issue 1, January 2016, Pages: 74–82, Jia-Feng Wu, Yu-Chun Chiu, Kai-Chi Chang, Huey-Ling Chen, Yen-Hsuan Ni, Hong-Yuan Hsu and Mei-Hwei Chang

    Version of Record online : 29 OCT 2015, DOI: 10.1002/hep.28222

  12. You have free access to this content
    Poster Session 3: Hepatitis B: Epidemiology and Natural History History

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 961A–1001A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28233

  13. You have free access to this content
    Poster Session 4: Stem Cell Biology; Varices and Bleeding

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 1195A–1215A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28243

  14. Pretreatment HBeAg level and an early decrease in HBeAg level predict virologic response to entecavir treatment for HBeAg-positive chronic hepatitis B

    Journal of Viral Hepatitis

    Volume 19, Issue 2, February 2012, Pages: e41–e47, J. H. Kwon, J. W. Jang, S. Lee, J. Lee, K. W. Chung, Y. S. Lee and J. Y. Choi

    Version of Record online : 20 NOV 2011, DOI: 10.1111/j.1365-2893.2011.01509.x

  15. You have free access to this content
    Serum hepatitis B virus RNA levels as an early predictor of hepatitis B envelope antigen seroconversion during treatment with polymerase inhibitors

    Hepatology

    Volume 61, Issue 1, January 2015, Pages: 66–76, Florian van Bömmel, Anne Bartens, Alena Mysickova, Jörg Hofmann, Detlev H. Krüger, Thomas Berg and Anke Edelmann

    Version of Record online : 25 NOV 2014, DOI: 10.1002/hep.27381

  16. Hepatitis B virus genotype B results in better immediate, late and sustained responses to peginterferon-alfa in hepatitis-B-e-antigen-positive patients

    Journal of Gastroenterology and Hepatology

    Volume 26, Issue 3, March 2011, Pages: 461–468, Chien-Hung Chen, Chuan-Mo Lee, Chao-Hung Hung, Jing-Houng Wang, Tsung-Hui Hu, Chi-Sin Changchien and Sheng-Nan Lu

    Version of Record online : 5 JUL 2010, DOI: 10.1111/j.1440-1746.2010.06429.x

  17. Five-year on-treatment efficacy of lamivudine-, tenofovir- and tenofovir + emtricitabine-based HAART in HBV–HIV-coinfected patients

    Journal of Viral Hepatitis

    Volume 19, Issue 11, November 2012, Pages: 801–810, L. Kosi, T. Reiberger, B. A. Payer, K. Grabmeier-Pfistershammer, R. Strassl, A. Rieger and M. Peck-Radosavljevic

    Version of Record online : 15 MAR 2012, DOI: 10.1111/j.1365-2893.2012.01601.x

  18. You have free access to this content
    Discontinuation of oral antivirals in chronic hepatitis B: A systematic review

    Hepatology

    Volume 63, Issue 5, May 2016, Pages: 1481–1492, George Papatheodoridis, Ioannis Vlachogiannakos, Evangelos Cholongitas, Karsten Wursthorn, Christos Thomadakis, Giota Touloumi and Jörg Petersen

    Version of Record online : 4 MAR 2016, DOI: 10.1002/hep.28438

  19. Expert recommendations on the application of interferon for chronic hepatitis B

    Journal of Digestive Diseases

    Volume 14, Issue 12, December 2013, Pages: 626–637, Mo Bin Wan and Xin Hua Weng

    Version of Record online : 5 NOV 2013, DOI: 10.1111/1751-2980.12096

  20. Monitoring of HBeAg levels may help to predict the outcomes of lamivudine therapy for HBeAg positive chronic hepatitis B

    Journal of Viral Hepatitis

    Volume 12, Issue 2, March 2005, Pages: 216–221, N. H. Park, J. W. Shin, J. H. Park, S-J. Bang, D-H. Kim, K. R. Joo and D. H. Kim

    Version of Record online : 17 FEB 2005, DOI: 10.1111/j.1365-2893.2005.00602.x